Tesla shares (TSLA)

Key Updates

Tesla shares surged 4.87% to $382.08 since the March 31 report, marking the strongest single-session gain in recent weeks and breaking above the $370 resistance level that has constrained price action throughout the downtrend. This rally was driven by two significant developments: positive European sales data showing Tesla's first year-over-year growth in the region in over a year, and CEO Elon Musk's announcement that the Terafab chip manufacturing project will launch within 7 days. The recovery brings shares closer to the $390-400 resistance zone but YTD losses remain substantial at -15.04%, reflecting ongoing investor skepticism about capital allocation and near-term profitability.

Current Trend

Tesla remains in a confirmed downtrend with YTD losses of 15.04%, though the 4.87% single-session gain represents a potential inflection point. The stock has declined 16.84% over six months and 5.27% over one month, establishing a clear pattern of lower highs and lower lows. The current price of $382.08 sits above the critical $370 support level that was breached in late March, suggesting a technical rebound attempt. However, the stock faces immediate resistance at $390-400, with the 6-month performance indicating sustained selling pressure. The recent recovery from $356.84 (March 30 low) to current levels represents a 7.1% bounce, but confirmation of trend reversal requires sustained trading above $400 with accompanying volume.

Investment Thesis

The investment thesis centers on Tesla's transformation from a pure-play EV manufacturer into a diversified technology conglomerate with exposure to autonomous driving, AI chip manufacturing, robotics, and energy storage. Bank of America's valuation framework assigns 54% of Tesla's value to robotaxi operations ($422 billion) and FSD software ($313 billion), compared to just 21% for traditional automotive operations ($345 billion), representing a fundamental shift in how the market should value the company. The thesis requires successful execution on multiple fronts: achieving regulatory approval for FSD in Europe and China, scaling robotaxi operations from 2 cities to 9 by year-end 2026, ramping Terafab chip production to meet internal AI demands, and maintaining automotive cash generation to fund $20+ billion in annual capex. The European sales recovery—13,740 units in February 2025, up 29% year-over-year—provides evidence that the core automotive business can stabilize through pricing adjustments and product refreshes, critical for funding the technology transformation.

Thesis Status

The thesis faces near-term execution challenges but long-term structural drivers remain intact. Positive developments include the first European sales growth in over a year, demonstrating pricing power and market share defense capabilities, and the imminent Terafab launch within 7 days, validating management's commitment to vertical integration in AI infrastructure. However, significant headwinds persist: Wall Street analysts project Tesla's free cash flow will turn negative in 2026 for the first time since 2018, with expected negative FCF of $4.1 billion as capex exceeds $20 billion excluding Terafab costs. The upcoming Q1 delivery report expecting 365,645 units (8% year-over-year growth) will test whether automotive revenue can sustain the technology investments. The thesis requires patience as Tesla enters a capital-intensive expansion phase with profitability pressure, but the European recovery and analyst upgrades (BofA $460-488 price targets representing 20-28% upside) suggest the market is beginning to price in the optionality of autonomous driving and AI infrastructure assets.

Key Drivers

Three catalysts are reshaping Tesla's near-term trajectory. First, European sales momentum with February 2025 registrations reaching 13,740 units (up 29% year-over-year) demonstrates that pricing adjustments on Model Y and Model 3 variants can reignite demand in mature markets, with FSD regulatory approval expected in the Netherlands during summer 2025 providing a pathway to EU-wide authorization. Second, the Terafab chip manufacturing initiative launching within 7 days represents a strategic pivot toward vertical integration, with Musk stating that TSMC, Samsung, and Micron cannot meet Tesla's AI chip demand, though UBS estimates initial capex of $30 billion and potential full-scale costs of $300 billion create significant financial risk. Third, the Q1 delivery report due imminently will determine whether Tesla can achieve 365,645 units (8% growth) while maintaining the $69.5 billion automotive revenue base that funds the technology transformation, particularly critical as the company holds $44 billion in cash but faces potential negative free cash flow. The Bank of America upgrade to buy with $460 price target and robotaxi expansion from 2 to 9 cities by year-end provides external validation of the autonomous driving strategy, though only 1.1 million of 8.9 million vehicles sold have purchased FSD subscriptions, indicating significant adoption challenges remain.

Technical Analysis

Tesla shares are attempting a technical reversal after establishing a YTD low of $356.84 on March 30. The 4.87% rally to $382.08 breaks above the $370 resistance level that capped gains in the March 31 session, suggesting accumulation at lower levels. The stock now trades 7.1% above the recent low but remains 15.04% below YTD starting levels, indicating the broader downtrend remains intact until $400 is decisively cleared. Key technical levels: immediate support at $370 (former resistance), secondary support at $360 (March 30 low), and critical resistance at $390-400 where previous rallies have failed. The 5-day decline of 1.00% and 1-month decline of 5.27% demonstrate persistent selling pressure on any rallies, while the 6-month decline of 16.84% establishes the dominant trend. Volume patterns during this 4.87% rally will be critical—sustained gains require confirmation through above-average volume, while low-volume rallies typically fail at resistance. The stock needs consecutive closes above $400 to signal a trend change, otherwise this represents a technical bounce within an established downtrend.

Bull Case

• European market recovery validates pricing power and demand stabilization: Tesla achieved 13,740 EU registrations in February 2025, up 29% year-over-year, marking the first sales growth in over a year and demonstrating that strategic pricing on Model Y and Model 3 variants can reignite demand in mature markets, with FSD regulatory approval expected in the Netherlands during summer 2025 providing a pathway to broader European monetization.
• Autonomous driving valuation represents 54% of enterprise value with near-term catalysts: Bank of America assigns $735 billion to autonomous vehicle and robotaxi businesses, more than double the $345 billion EV division valuation, with robotaxi expansion from 2 cities to 9 by year-end 2026 and projected $1.58 cost per mile at scale versus $3.41 for traditional ride-sharing creating a substantial competitive moat.
• Vertical integration in AI chip manufacturing addresses critical supply constraint: The Terafab Project launching within 7 days targets production of AI5 chips for volume manufacturing in 2027, with Musk stating current partners TSMC, Samsung, and Micron cannot meet Tesla's future AI chip demand, positioning the company to capture value across the entire AI infrastructure stack.
• Automotive business generates sufficient cash to fund technology transformation: Tesla's automotive operations produced $69.5 billion in revenue last year, more than double the rest of the company, with $44 billion in cash at year-end 2025 providing a substantial buffer to fund the $20+ billion annual capex requirements while the Q1 delivery report expects 365,645 units representing 8% year-over-year growth.
• Multiple analysts upgraded Tesla with 20-28% upside targets based on technology optionality: Bank of America resumed coverage with a buy rating and $488 price target, representing 28% upside from current levels, with Wall Street projecting Tesla could capture up to 50% of the global robotaxi market and Morgan Stanley forecasting 5 million robotaxis on roads by 2035.

Bear Case

• Free cash flow turning negative for first time since 2018 amid massive capex requirements: Wall Street analysts project negative FCF of $4.1 billion in 2026 as Tesla plans $20+ billion in capex excluding Terafab costs, with UBS estimating Terafab alone could require $30 billion initially and potentially $300 billion at full production capacity, creating significant financial strain and potential dilution risk.
• Automotive delivery growth remains anemic while investor focus shifts to unproven technologies: The upcoming Q1 delivery report expects 365,645 units representing only 8% year-over-year growth, with UBS analyst Joseph Spak noting deliveries may not significantly drive stock performance as before, yet automotive generated $69.5 billion in revenue—the foundation funding all technology investments—creating execution risk if core business deteriorates.
• FSD adoption remains minimal with only 12.4% of vehicles sold purchasing the technology: Despite autonomous driving representing 54% of Tesla's valuation, only 1.1 million of 8.9 million vehicles sold have purchased FSD subscriptions, requiring Tesla to reach 8.7 million FSD customers by 2030 per BofA's analysis—a nearly 8x increase that demands regulatory approval in China and Europe where progress remains uncertain.
• Stock declined 23% over three months amid broader skepticism around AI investments: Tesla shares have fallen 23% over the past three months with YTD losses of 15.04%, reflecting investor rotation out of tech stocks and skepticism around capital-intensive AI projects, while the stock had fallen 13% year-to-date through early March despite 44% gains over the prior 12 months, indicating momentum has reversed.
• Robotaxi expansion faces regulatory and operational hurdles with minimal current scale: Tesla currently operates ride-hailing services in only 2 cities with plans to expand to 9 by year-end 2026, yet Morgan Stanley forecasts only 1,000 robotaxis by end of 2026 compared to a target of 5 million by 2035, indicating massive execution risk in scaling operations while competitors like Waymo already operate commercial services at greater scale in multiple markets.